Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2013; 19(6): 923-930
Published online Feb 14, 2013. doi: 10.3748/wjg.v19.i6.923
Published online Feb 14, 2013. doi: 10.3748/wjg.v19.i6.923
Table 1 Characteristics of 5616 cancer patients who received chemotherapy n (%)
| Characteristics | Hematological malignancy | Solid tumor | Total | |
| (n = 281) | HCC(n = 237) | Others(n = 5098) | (n = 5616) | |
| Age (yr), mean (range) | 50.5 (18-83) | 53.1 (39-67) | 54.4 (41-67) | 54.1 (29-79) |
| Sex | ||||
| Men | 176 (62.6) | 201 (84.8) | 2567 (50.4) | 2944 (52.4) |
| Women | 105 (37.4) | 36 (17.9) | 2531 (49.6) | 2672 (47.6) |
| Surgical history | 22 (7.8) | 6 (2.5) | 2157 (42.3) | 2185 (38.9) |
| History of HBV infection1 | 27 (9.6) | 126 (53.2) | 179 (3.5) | 332 (5.9) |
| Aminotransferase | ||||
| Normal (< 58 IU/mL) | 251 (89.3) | 144 (60.8) | 4816 (94.5) | 5211 (92.8) |
| Elevated | 30 (10.7) | 93 (39.2) | 282 (5.5) | 405 (7.2) |
- Citation: Wang Y, Luo XM, Yang D, Zhang J, Zhuo HY, Zhang J, Jiang Y. Testing for hepatitis B infection in prospective chemotherapy patients: A retrospective study. World J Gastroenterol 2013; 19(6): 923-930
- URL: https://www.wjgnet.com/1007-9327/full/v19/i6/923.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i6.923